These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7961924)

  • 1. Role of N- and C-terminal amino acids in antithrombin binding to pentasaccharide.
    Mille B; Watton J; Barrowcliffe TW; Mani JC; Lane DA
    J Biol Chem; 1994 Nov; 269(47):29435-43. PubMed ID: 7961924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational change in antithrombin induced by heparin probed with a monoclonal antibody against the 1C/4B region.
    Dawes J; James K; Lane DA
    Biochemistry; 1994 Apr; 33(14):4375-83. PubMed ID: 7512382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of N-terminal region residues Lys11, Arg13, and Arg24 of antithrombin in heparin recognition and in promotion and stabilization of the heparin-induced conformational change.
    Schedin-Weiss S; Desai UR; Bock SC; Olson ST; Björk I
    Biochemistry; 2004 Jan; 43(3):675-83. PubMed ID: 14730971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The region of antithrombin interacting with full-length heparin chains outside the high-affinity pentasaccharide sequence extends to Lys136 but not to Lys139.
    Arocas V; Turk B; Bock SC; Olson ST; Björk I
    Biochemistry; 2000 Jul; 39(29):8512-8. PubMed ID: 10913257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Arg46 and Arg47 of antithrombin in heparin binding.
    Arocas V; Bock SC; Olson ST; Björk I
    Biochemistry; 1999 Aug; 38(31):10196-204. PubMed ID: 10433728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysine 114 of antithrombin is of crucial importance for the affinity and kinetics of heparin pentasaccharide binding.
    Arocas V; Bock SC; Raja S; Olson ST; Bjork I
    J Biol Chem; 2001 Nov; 276(47):43809-17. PubMed ID: 11567021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombins Southport (Leu 99 to Val) and Vienna (Gln 118 to Pro): two novel antithrombin variants with abnormal heparin binding.
    Chowdhury V; Mille B; Olds RJ; Lane DA; Watton J; Barrowcliffe TW; Pabinger I; Woodcock BE; Thein SL
    Br J Haematol; 1995 Mar; 89(3):602-9. PubMed ID: 7734360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin and its deficiency states.
    Lane DA; Olds RR; Thein SL
    Blood Coagul Fibrinolysis; 1992 Jun; 3(3):315-41. PubMed ID: 1643210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.
    Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J
    J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction of a mutation in the shutter region of antithrombin (Phe77 --> Leu) increases affinity for heparin and decreases thermal stability.
    Quinsey NS; Fitton HL; Coughlin P; Whisstock JC; Dafforn TR; Carrell RW; Bottomley SP; Pike RN
    Biochemistry; 2003 Sep; 42(34):10169-73. PubMed ID: 12939144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of lysine 125 for heparin binding and activation of antithrombin.
    Schedin-Weiss S; Desai UR; Bock SC; Gettins PG; Olson ST; Björk I
    Biochemistry; 2002 Apr; 41(15):4779-88. PubMed ID: 11939772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The signature 3-O-sulfo group of the anticoagulant heparin sequence is critical for heparin binding to antithrombin but is not required for allosteric activation.
    Richard B; Swanson R; Olson ST
    J Biol Chem; 2009 Oct; 284(40):27054-64. PubMed ID: 19661062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of arginine 129 in heparin binding and activation of antithrombin.
    Desai U; Swanson R; Bock SC; Bjork I; Olson ST
    J Biol Chem; 2000 Jun; 275(25):18976-84. PubMed ID: 10764763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants.
    Fan B; Turko IV; Gettins PG
    Biochemistry; 1994 Nov; 33(47):14156-61. PubMed ID: 7947827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative Interactions of Three Hotspot Heparin Binding Residues Are Critical for Allosteric Activation of Antithrombin by Heparin.
    Richard B; Swanson R; Izaguirre G; Olson ST
    Biochemistry; 2018 Apr; 57(15):2211-2226. PubMed ID: 29561141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of the basic side chains of Lys114, Lys125, and Arg129 of antithrombin in heparin binding.
    Schedin-Weiss S; Arocas V; Bock SC; Olson ST; Björk I
    Biochemistry; 2002 Oct; 41(41):12369-76. PubMed ID: 12369826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin binding affinity of normal and genetically modified antithrombin III measured using a monoclonal antibody to the heparin binding site of antithrombin III.
    Watton J; Longstaff C; Lane DA; Barrowcliffe TW
    Biochemistry; 1993 Jul; 32(28):7286-93. PubMed ID: 8343518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a reducing-end extension on pentasaccharide binding by antithrombin.
    Belzar KJ; Dafforn TR; Petitou M; Carrell RW; Huntington JA
    J Biol Chem; 2000 Mar; 275(12):8733-41. PubMed ID: 10722716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
    Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
    Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Mechanisms of the Impaired Heparin Pentasaccharide Interactions in 10 Antithrombin Heparin Binding Site Mutants Revealed by Enhanced Sampling Molecular Dynamics.
    Balogh G; Bereczky Z
    Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.